INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2010
Total net assets |
£99.6m |
NAV per share |
166.1p |
Share price |
139.0p |
Total value of unquoted investments |
£22.7m |
Total number of portfolio companies |
60 |
Cash |
(3)% NAV |
Cash committed and reserved to unquoted investments |
9% NAV |
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
6.40 |
Micromet |
5.87 |
Amgen |
5.59 |
Gilhead Sciences |
5.11 |
Shire Ltd |
5.04 |
Alexion Pharmaceuticals |
3.90 |
Insulet |
3.66 |
Teva |
3.38 |
Genzyme |
3.33 |
Cadent |
3.16 |
|
----------- |
Total |
45.44 |
Geographical Allocation |
% |
United States |
78 |
Europe |
23 |
Australia |
2 |
Cash |
(3) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
80 |
Unquoted |
23 |
Cash |
(3) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
16 NOVEMBER 2010